Profile of Intravenous Admixture Drugs in Newborn Patients at Dr. Moewardi General Hospital Surakarta
DOI:
https://doi.org/10.30595/pharmacy.v20i2.21236Keywords:
Compatibility, Incompatibility, Intravenous Drugs Administration, NewbornAbstract
Intravenous admixtures are sterile solutions prepared by mixing one or more different drugs with a suitable solvent and given to patients via the intravenous route. One of the factors causing contamination of the intravenous preparation mixture is an error in the aseptic technique during the preparation phase. Errors in aseptic techniques can cause infection. Newborns (neonates) are children under the age of 28 days. During 28 days of birth, have the highest risk of dying. The rate of potential adverse drug events (ADE) is three times higher in children than adults and substantially higher in neonates receiving intensive care. Intravenous admixture therapy, often performed in general wards, is highly susceptible to bacterial contamination which can result from aseptic technique errors. Bacterial contamination in intravenous preparations can cause infection which can trigger septic shock to death. The purpose of this study was to evaluate the suitability of the mixing process and the process of administering intravenous admixture drugs to infant patients. This study was conducted on infant or neonatal patients who were hospitalized in general wards and special intensive wards for babies in hospitals. Dr. Moewardi Surakarta. The research took place from February to March 2020 and was carried out using a prospective observational method. The inclusion criteria for this study were patients receiving parenteral drug therapy with complete medical records. Analysis of drug miscibility/insolubility was carried out using Handbook an Injectable Drugs edition 17 as the main reference and ASHP Drug information handbook 2021 edition. The results of this study, the percentage of solubility of injectable drugs that dissolved was 44 times administration (36.7%). For the administration of insoluble drugs 3 times (2.5%) and 73 (60.8%) administrations there was no information regarding the solubility of the drugs given. The study concludes that although there is incompatibility potential information references, at the direct observation was no incompatibility found. The administration of the two potentially insoluble drugs was carried out with different syringe containers.
References
Arumugam, V. et al. 2016. A prospective study on medication and total parenteral nutrition practices at a Neonatal Intensive Care Unit. Archives of Pharmacy Practice, 7(4), 142. https://doi.org/10.4103/2045-080x.191930.
ASHP® Injectable Drug Information, 2021 Edition: A Comprehensive Guide to Compatibility and Stabilityhttps://doi.org/10.37573/9781585286850
Campino, A. et al. 2017. Intravenous medicine preparation technique training programme for nurses in clinical areas,†European Journal of Hospital Pharmacy, 298–300. https://doi.org/10.1136/ejhpharm-2016-000947.
Demissie, B.W. et al. 2018, Neonatal hypothermia and associated factors among neonates admitted to neonatal intensive care unit of public hospitals in Addis Ababa, Ethiopia,†BMC Pediatrics, 18(1), 1–10. https://doi.org/10.1186/s12887-018-1238-0.
Kalikstad, B., Skjerdal, Å. dan Hansen, T.W.R. 2010. Compatibility of drug infusions in the NICU. Archives of Disease in Childhood, 95(9), 745–748. https://doi.org/10.1136/adc.2009.174268.
Lyons, I. et al. 2018. Errors and discrepancies in the administration of intravenous infusions: A mixed methods multihospital observational study. BMJ Quality and Safety, 27(11), 892–901. https://doi.org/10.1136/bmjqs-2017-007476.
Maison, O. et al. 2019. Drug incompatibilities in intravenous therapy: evaluation and proposition of preventive tools in intensive care and hematology units. European Journal of Clinical Pharmacology, 75(2), 179–187. https://doi.org/10.1007/s00228-018-2602-6.
Mengesha, E.W. et al. 2022. Parental experiences in neonatal intensive care unit in Ethiopia: A phenomenological study. Annals of Medicine, 54(1), 21–131. https://doi.org/10.1080/07853890.2021.2004320.
Nguyen, H.T. et al. 2015. Medication errors in Vietnamese hospitals: Prevalence, potential outcome and associated factors. PLoS ONE, 10(9). https://doi.org/10.1371/journal.pone.0138284.
Suvikas-Peltonen, E. et al. 2017. Incorrect aseptic techniques in medicine preparation and recommendations for safer practices: A systematic review. European Journal of Hospital Pharmacy. 175–181. https://doi.org/10.1136/ejhpharm-2016-001015.
Bano, T., Zulfiqar, S. dan Shiekh, T. K. 2022. Effect of electrolyte addition in fluids to reduce mortality in neonates. The Professional Medical Journal, 29(06), 813–817. https://doi.org/10.29309/tpmj/2022.29.06.6801.
Trissel, L.A, et.al., 2013. Hanbook on Injectable Drugs. 17th Ed, New York: American Society of Health System Pharmacists.
Ziesenitz, V.C. et al. 2019. Prescription drug shortages: Impact on neonatal intensive care. Neonatology, 115(2), 108–115. https://doi.org/10.1159/000493119.
Downloads
Published
Issue
Section
License
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution 4.0 International License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).
